We are delighted that The UK has signed up to associate to Horizon Europe, this will give us certainty that has been missing for a number of years now. Carl Diver, Professor of Innovative Manufacturing, Manchester Metropolitan University & Director - PrintCity MMU The collaborative nature of Horizon grants means that there will now be greater opportunity to progress other, close to market, pipeline projects with cross-discipline European partners. These steps are usually required to convince large pharma companies to progress novel therapeutics and drug delivery systems to later stage trials and commercial application. This funding is most useful to small biotech companies to generate early stage pre-clinical and clinical safety and performance evidence ahead of larger scale trials. For Renishaw Neuro Solutions, it means we can explore innovative therapy developments where our direct drug delivery technology can be used to treat brain conditions that traditionally have been difficult to treat. This positive step provides a framework and potential funding for collaborative programmes with European partners. This week's announcement that the UK is rejoining the Horizon scientific programme is great news for Renishaw and other UK businesses committed to R&D. Rupert Jones, Managing Director, Renishaw plc – Medical, Renishaw Neuro Solutions Ltd This is a fantastic opportunity for UK businesses and organisations to showcase their innovation and expertise on the world stage. It is a very positive step forward for the UK.īy working together with our European partners, UK companies, universities, and research organisations will now have greater opportunities to access funding, lead projects, and increase their influence across the global research and development landscape. This decision also signifies the UK’s commitment to advancing scientific knowledge and addressing challenges together in collaboration with the wider scientific community. This decision will do a great deal to strengthen the UK ties with the EU in the field of research and innovation. It is great news that the UK has rejoined the Horizon Europe science and research programme. I am sure that the entire UK academic community wholeheartedly welcomes the news of the UK re-joining Horizon Europe and looks forward to working again with our European partners on maintain Europe’s leadership in this sector. These programmes also provide an excellent opportunity for training the future generations of additive manufacturing engineers and scientists through the doctoral training networks, and for attracting foreign talents from all over the world through the Marie-Sklodowska Curie fellowships. The UK’s strong participation in the previous programmes created opportunities for businesses and research and technology organisations to engage and jointly develop novel innovations and transfer knowledge to the end-users. (AMPLAB), Director of Research & Knowledge Transfer, University of Birminghamįor years, the additive manufacturing sector in Europe maintained its leadership thanks to the generous support it has been receiving through the EU-funded programmes. Professor Moataz Attallah, Director, The Advanced Materials Processing Lab. The end to the uncertainty over the UK’s long-term status in the Horizon programme will enable the UK’s AM research and industrial community to plan with confidence for the future, and enable our country to join the governance of the EU programmes. This has led to key advances in machinery, software, materials and applications that have significantly benefitted the UK’s high value manufacturing sector. Over the last four decades, EU funded projects have played a critical role in the development of AM technology. David Wimpenny, Chief Technologist, NCAM, MTC
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |